Recent Progress of Deep Learning in Healthcare

Dear Colleagues,

The field of healthcare stands at the cusp of a transformation, driven by the rapid advancements in artificial intelligence. Deep learning, a subset of machine learning, has shown unprecedented success in interpreting complex data, making it a potent tool for clinical decision support, medical diagnostics, treatment planning, and disease prediction. By analyzing complex medical data, these algorithms enhance the management of chronic disease, improve diagnostic accuracy, and aid in early disease detection. They also revolutionize personalized medicine, tailoring treatments to individual genetic and health profiles. In drug development, deep learning accelerates the discovery and testing of new drugs. Additionally, it supports clinicians with decision-making tools and powers health monitoring wearables, offering real-time insights into patient health. This technology is not just transforming how healthcare is delivered, but also improving patient outcomes, making healthcare more accessible, effective, and personalized.

This Special Issue aims to provide a comprehensive overview of the current state and future potential of deep learning in healthcare. It features pioneering research demonstrating the use of these algorithms in applications to complex diseases, such as diabetes, dementia, and cardiovascular diseases, offering insights into the innovations that are set to redefine healthcare in the coming years.

Dr. Taiyu Zhu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• deep learning
• personalized medicine
• digital health
• bioinformatics
• genomic data analysis